The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

At the top of the list ... ad Pharmacy benefit managers were originally intended to help insurance companies manage claims and lower patient drug costs. But today, according to the Federal Trade ...

The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...

Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...

The fourth annual list spotlighting the most auspicious unmade LGBTQ-inclusive scripts in town chose 10 finalists across a variety of genres. It is pretty good company, if for no other reason than ...

Supply isn’t meeting demand for many pharmacies in the province when it comes to COVID-19 vaccines. Many pharmacies are running out of vaccines before they get their next shipment, according to ...

Executives from Amazon, Walgreens, Blue Shield of California and PhRMA weighed in on how to fix the much-scrutinized pharmacy ...

as part of its new express delivery option. The retail bellwether's latest move comes a couple of weeks after technology giant Amazon.com AMZN.O announced its plans to open pharmacies with ...

The biggest pharmacy benefit managers are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.